Hull R W, Snow F, Herre J, Ellenbogen K A
Cardiac Electrophysiology Laboratory, Medical College of Virginia, Richmond 23298.
Pacing Clin Electrophysiol. 1990 Nov;13(11 Pt 1):1408-15. doi: 10.1111/j.1540-8159.1990.tb04016.x.
Many patients with VVI and VVIR pacemakers will alternate between periods of sinus rhythm and ventricular pacing. These rhythm shifts may be poorly tolerated by some patients. Changes in plasma catecholamine levels during these rhythm shifts may contribute to these patients' symptoms. We measured blood pressure, ejection fraction and plasma norepinephrine, epinephrine, and dopamine serially in nine patients with normal left ventricular ejection fractions and VVI pacemakers during sinus rhythm and at paced rates of 10 beats per minute (bpm) above sinus rates (10 + NSR), 100 bpm, and 130 bpm. The mean norepinephrine level at baseline was 143 +/- 16 pg/mL and increased to 166 +/- 36 pg/mL at 10 + NSR, 204 +/- 47 pg/mL at 100 bpm, and 182 +/- 34 pg/mL at 130 bpm. These increases corresponded to mean percent changes from baseline of 17% (P = 0.02), 33% (P = 0.002), and 24% (P = 0.07), respectively. The magnitude of the norepinephrine response was not correlated with the pacing rate. The mean plasma epinephrine level at baseline was 57 +/- 6 pg/mL and peaked at 51 +/- 12 pg/mL at 10 + NSR, 89 +/- 31 pg/mL at 100 bpm and 101 +/- 28 pg/mL at 130 bpm. These increases corresponded to mean percent changes from baseline of -10% (P = NS), 30% (P = 0.07), and 89% (P = 0.02), respectively. No trends in the dopamine response to pacing were noted. During ventricular pacing there were no significant changes in mean blood pressure and only slight changes in ejection fraction. The individual percent changes in plasma norepinephrine and epinephrine at 100 bpm were inversely correlated to the changes in systolic blood pressure (R = -0.68, P = 0.06, and R = -0.81, P = 0.03, respectively). These results suggest that plasma norepinephrine and epinephrine increase acutely in response to ventricular pacing at rates commonly seen during rate responsive ventricular pacing.
许多植入VVI和VVIR起搏器的患者会在窦性心律和心室起搏之间交替。这些心律变化可能有些患者难以耐受。这些心律变化期间血浆儿茶酚胺水平的改变可能导致这些患者出现症状。我们连续测量了9名左心室射血分数正常且植入VVI起搏器的患者在窦性心律时以及起搏频率比窦性心律快10次/分钟(bpm)(10 + NSR)、100 bpm和130 bpm时的血压、射血分数以及血浆去甲肾上腺素、肾上腺素和多巴胺水平。基线时去甲肾上腺素的平均水平为143±16 pg/mL,在10 + NSR时升至166±36 pg/mL,100 bpm时为204±47 pg/mL,130 bpm时为182±34 pg/mL。这些升高分别对应于相对于基线的平均变化百分比为17%(P = 0.02)、33%(P = 0.002)和24%(P = 0.07)。去甲肾上腺素反应的幅度与起搏频率无关。基线时血浆肾上腺素的平均水平为57±6 pg/mL,在10 + NSR时峰值为51±12 pg/mL,100 bpm时为89±31 pg/mL,130 bpm时为101±28 pg/mL。这些升高分别对应于相对于基线的平均变化百分比为 -10%(P =无统计学意义)、30%(P = 0.07)和89%(P = 0.02)。未观察到多巴胺对起搏反应的趋势。在心室起搏期间,平均血压无显著变化,射血分数仅有轻微变化。在100 bpm时血浆去甲肾上腺素和肾上腺素的个体变化百分比与收缩压变化呈负相关(分别为R = -0.68,P = 0.06和R = -0.81,P = 0.03)。这些结果表明,在频率应答性心室起搏常见的频率下,心室起搏会使血浆去甲肾上腺素和肾上腺素急性升高。